Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jessica A. Zavadil"'
Publikováno v:
PLoS ONE, Vol 18, Iss 1, p e0279875 (2023)
Bioluminescence imaging (BLI) of gene expression in live animals is a powerful method for monitoring development, tumor growth, infections, healing, and other progressive, long-term biological processes. BLI remains an effective approach for reducing
Externí odkaz:
https://doaj.org/article/b3f46e3f6a71457aa862962431f9d12f
Autor:
Bryan A. Sisk, Jessica A. Zavadil, Lindsay J. Blazin, Justin N. Baker, Jennifer W. Mack, James M. DuBois
Publikováno v:
JCO Oncol Pract
PURPOSE:Communication breakdowns in pediatric oncology can have negative consequences for patients and families. A detailed analysis of these negative encounters will support clinicians in anticipating and responding to communication breakdowns.METHO
Autor:
William T. Boswell, Kim Hildreth, Robert L. Reddick, Christi A. Walter, Maryanne C. Herzig, Amir Foroushani, Jessica A. Zavadil, Habil Zare, Ronald B. Walter, Hugh White
Publikováno v:
Molecular Carcinogenesis. 58:309-320
Hepatocellular carcinoma (HCC) remains a deadly cancer, underscoring the need for relevant preclinical models. Male C3HeB/FeJ mice model spontaneous HCC with some hepatocarcinogenesis susceptibility loci corresponding to syntenic regions of human chr
Autor:
Norman R. Drinkwater, Maryanne C. Herzig, Traci L. Reddick, Karah Street, Kim Hildreth, Christi A. Walter, Robert L. Reddick, C. Alex McMahan, Damon C. Herbert, Martha A. Hanes, Jessica A. Zavadil
Publikováno v:
Cancer Prevention Research. 9:245-252
Hepatocellular carcinoma is increasingly important in the United States as the incidence rate rose over the last 30 years. C3HeB/FeJ mice serve as a unique model to study hepatocellular carcinoma tumorigenesis because they mimic human hepatocellular
Autor:
Christi A. Walter, Jessica A. Zavadil
Publikováno v:
Cancer Research. 76:3595-3595
Eighty percent of hepatocellular carcinoma (HCC) within the USA is diagnosed late when chemotherapy provides only 2 months increased survival. We fortuitously found that treatment with an alkylating agent, methylnitrosurea (MNU), prior to tumorigenes